title: [Nle3,d-Phe6 ]-γ2 -melanocyte-stimulating hormone possesses the renal excretory but not the cardiovascular actions of the native γ2 -melanocyte-stimulating hormone in anaesthetized rats.
abstract: The present study compared the cardiovascular and renal actions of γ(2) -melanocyte-stimulating hormone (γ(2) MSH) with those of the synthetic analogue [Nle(3) ,d-Phe(6) ]-γ(2) MSH (NDP-γ(2) MSH) and explored the effects of high dietary salt intake on the renal actions of NDP-γ(2) MSH. Both peptides were infused systemically (3-1000 nmol/kg) and intrarenally (500 fmol/min) into innervated and renally denervated rats fed either a normal (0.4% NaCl) or high-salt (4% NaCl; HS) diet. Mean arterial pressure (MAP), glomerular filtration rate (GFR), urinary sodium excretion (U(N) (a) V), urinary output (UV) and fractional sodium excretion were determined, as was expression of the melanocortin MC(3) receptor in inner medullary collecting duct (IMCD) epithelial cells. Both renal and systemic infusion of γ(2) MSH increased MAP by 23 ± 2% and 54 ± 4%, respectively, but equivalent doses of NDP-γ(2) MSH had no significant pressor effects. Both peptides had similar natriuretic and diuretic effects in rats fed a normal salt diet. However, NDP-γ(2) MSH increased U(N) (a) V and UV by two- to threefold in rats fed the normal salt diet and by six- to sevenfold in rats fed the HS diet. Furthermore, NDP-γ(2) MSH induced a 3.5-fold increase in GFR only in rats fed the HS diet. These renal effects of NDP-γ(2) MSH were not abolished by prior renal denervation. Rats fed the HS diet also exhibited a 4.5-fold increase in MC(3) receptor expression in IMCD epithelial cells. Intrarenal infusion of NDP-γ(2) MSH induced the natriuretic but not the cardiovascular effects exhibited by γ(2) MSH. The renal activities may be attributed to a direct binding of NDP-γ(2) MSH to MC(3) receptors expressed in IMCD cells, leading to a potent natriuretic effect that is independent of renal innervation.
authors.affiliation: Department of Physiology, University College Cork, Cork, Ireland.
authors.forename: Georgina
authors.initials: G
authors.lastname: Cope
authors.forename: Evelyn T
authors.initials: ET
authors.lastname: Flanagan
authors.forename: Belinda L
authors.initials: BL
authors.lastname: Houghton
authors.forename: Sarah A
authors.initials: SA
authors.lastname: Walsh
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Johns
authors.forename: Vincent
authors.initials: V
authors.lastname: Healy
mesh_terms: D000818:Animals; D062186:Arterial Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects* / Q000378:metabolism; D003714:Denervation / Q000379:methods; D004232:Diuretics / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007679:Kidney Medulla / Q000187:drug effects* / Q000378:metabolism; D007685:Kidney Tubules, Collecting / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D045283:Natriuretic Agents / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D044104:Receptor, Melanocortin, Type 3 / Q000378:metabolism; D012492:Salts / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D017673:Sodium Chloride, Dietary / Q000378:metabolism; D000521:alpha-MSH / Q000031:analogs & derivatives / Q000494:pharmacology; D019825:gamma-MSH / Q000494:pharmacology*
chemical_list: D004232:Diuretics; D045283:Natriuretic Agents; D044104:Receptor, Melanocortin, Type 3; D012492:Salts; D017673:Sodium Chloride, Dietary; D019825:gamma-MSH; D000521:alpha-MSH; C027756:MSH, 4-Nle-7-Phe-alpha-; D012964:Sodium